Vivacelle Bio’s President and Chief Innovation Officer to Present Data Highlighting the Company’s Late-Stage Clinical Programs at the BIO International Convention 2024
Vivacelle is advancing a robust pipeline of therapies for shock and trauma-induced conditions Vivacelle’s pipeline is led by VBI-S, a…
